![Deborah Marshall](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Deborah Marshall
Keine laufenden Positionen mehr
Profil
Deborah Marshall was the President & Director at the International Society for Pharmacoeconomics & Outcomes Rsch.
She holds a doctorate degree from The University of North Carolina at Charlotte, a graduate degree from the University of Alberta, and an undergraduate degree from the University of Toronto.
Ehemalige bekannte Positionen von Deborah Marshall
Unternehmen | Position | Ende |
---|---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Präsident | 09.07.2013 |
Ausbildung von Deborah Marshall
University of Toronto | Undergraduate Degree |
University of Alberta | Graduate Degree |
The University of North Carolina at Charlotte | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
International Society for Pharmacoeconomics & Outcomes Rsch
![]() International Society for Pharmacoeconomics & Outcomes Rsch Miscellaneous Commercial ServicesCommercial Services International Society for Pharmacoeconomics & Outcomes Research provides health care researches. The organization have health care researchers from all disciplines conducting health care outcomes research. These disciplines include pharmacoeconomics (health economics), epidemiology (pharmacoepidemiology), decision analysis, modeling, risk assessment, patient-reported outcomes (quality of life), use of ‘real world’ data such as health care database analyses, observational studies, patient registries. | Commercial Services |